Epoxyeicosatrienoic Acids and Soluble Epoxide Hydrolase in Physiology and Diseases of the Central Nervous System
Authors:
- 1 January 2022
- journal article
- review article
- Published by Medknow in Chinese Journal of Physiology
- Vol. 65 (1) , 1-11
Abstract
Epoxyeicosatrienoic acids (EETs) are fatty acid signaling molecules synthesized by cytochrome P450 epoxygenases from arachidonic acid. The biological activity of EETs is terminated when being metabolized by soluble epoxide hydrolase (sEH), a process that serves as a key regulator of tissue EETs levels. EETs act through several signaling pathways to mediate various beneficial effects, including anti-inflammation, anti-apoptosis, and anti-oxidation with relieve of endoplasmic reticulum stress, thereby sEH has become a potential therapeutic target in cardiovascular disease and cancer therapy. Enzymes for EET biosynthesis and metabolism are both widely detected in both neuron and glial cells in the central nervous system (CNS). Recent studies discovered that astrocyte-derived EETs not only mediate neurovascular coupling and neuronal excitability by maintaining glutamate homeostasis but also glia-dependent neuroprotection. Genetic ablation as well as pharmacologic inhibition of sEH has greatly helped to elucidate the physiologic actions of EETs, and maintaining or elevating brain EETs level has been demonstrated beneficial effects in CNS disease models. Here, we review the literature regarding the studies on the bioactivity of EETs and their metabolic enzyme sEH with special attention paid to their action mechanisms in the CNS, including their modulation of neuronal activity, attenuation of neuroinflammation, regulation of cerebral blood flow, and improvement of neuronal and glial cells survival. We further reviewed the recent advance on the potential application of sEH inhibition for treating cerebrovascular disease, epilepsy, and pain disorder.Keywords
This publication has 98 references indexed in Scilit:
- Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic miceProstaglandins & Other Lipid Mediators, 2012
- Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetesProceedings of the National Academy of Sciences, 2012
- N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthaseCardiovascular Research, 2011
- Cytochrome P450 eicosanoids and cerebral vascular functionExpert Reviews in Molecular Medicine, 2011
- Multiple neurotrophic effects of VEGF on cultured neuronsNeuropeptides, 2010
- Epoxyeicosanoid signaling in CNS function and diseaseProstaglandins & Other Lipid Mediators, 2010
- Role of Soluble Epoxide Hydrolase in the Sex-Specific Vascular Response to Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2009
- Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathwaysProceedings of the National Academy of Sciences, 2008
- Soluble Epoxide Hydrolase: A Novel Therapeutic Target in StrokeJournal of Cerebral Blood Flow & Metabolism, 2007
- Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitorsProceedings of the National Academy of Sciences, 2006